...
首页> 外文期刊>Neuropsychiatric Disease and Treatment >Tanshinone IIA Promotes M2 Microglia by ERβ/IL-10 Pathway and Attenuates Neuronal Loss in Mouse TBI Model
【24h】

Tanshinone IIA Promotes M2 Microglia by ERβ/IL-10 Pathway and Attenuates Neuronal Loss in Mouse TBI Model

机译:丹参酮IIA通过ERβ/ IL-10途径推广M2微胶质,并衰减小鼠TBI模型中的神经元损失

获取原文

摘要

Purpose:Traumatic brain injury (TBI) is a major cause of morbidity and mortality worldwide. Increasing evidence indicates that activated microglia play an important role in the inflammatory response in TBI. Inhibiting M1 and stimulating M2 activated microglia have protective effects in several animal models of central nervous system (CNS) disorders. In the present study, we investigated whether tanshinone IIA (TNA) protects neurons by shifting microglia polarization in a mouse TBI model and further investigated the mechanism in vitro.Materials and Methods:Forty C57BL/6 mice were used to investigate the effect of TNA on microglia polarization in TBI. BV-2 cells were used to examine the mechanism of TNA in regulating microglia polarization.Results:Normal saline (NS), TNA and the combination of TNA with ICI 182,780 (ICI, an estrogen receptor antagonist) were used to treat the TBI mice. After TBI, mice from each group demonstrated functional improvement. The improvement rate in mice treated with TNA was faster than other groups. ICI partially reversed the benefits from TNA treatment. TNA treatment significantly reduced TBI-induced neuronal loss. The number of microglia after TBI was not significantly changed by TNA treatment. However, TNA treatment significantly decreased M1 macrophage markers (iNOS, TNFα and IL-1β) and increased M2 macrophage markers (CD206, arginase 1 and Ym1). This effect was partially abolished by ICI. TNA treatment downregulated M1 macrophage markers and upregulated M2 macrophage markers in BV-2 cells under LPS stimulation. IL-10 was significantly increased by TNA treatment without a significantly change of IL-4 and IL-13 expression. IL-10 knockdown completely abolished the effect of TNA on microglial M2 polarization.Conclusion:Taken together, our data demonstrated that TNA attenuates neuronal loss in mouse TBI model and promotes M2 microglia by ERβ/IL-10 pathway. Thus, TNA could be a potential drug for TBI and/or the disorders that caused by microglial over-activation in CNS.? 2020 Chen et al.
机译:目的:创伤性脑损伤(TBI)是全世界发病率和死亡率的主要原因。越来越多的证据表明活化的微胶质细胞在TBI炎症反应中发挥着重要作用。抑制M1和刺激的M2活性微胶质细胞在中枢神经系统(CNS)疾病的几种动物模型中具有保护作用。在本研究中,我们研究了丹参酮IIA(TNA)是否通过在小鼠TBI模型中移位小凝血胶质偏振来保护神经元,并进一步研究了体外的机制和方法:用于研究TNA对TNA的影响TBI中的小凝血症极化。使用BV-2细胞检查TNA在调节微胶质细胞偏振中的机制。结果:用于治疗TBI小鼠的正常盐水(NS),TNA和TNA的TNA的组合(ICI,雌激素受体拮抗剂)。 TBI后,来自每组的小鼠表现出功能性改进。用TNA处理的小鼠的提高率比其他基团更快。 ICI部分逆转了TNA治疗的益处。 TNA治疗显着降低了TBI诱导的神经元损失。 TNA治疗没有显着改变TBI后的微胶质细胞的数量。然而,TNA治疗显着降低了M1巨噬细胞标记物(INOS,TNFα和IL-1β)和增加的M2巨噬细胞标记物(CD206,氨基酶1和YM1)。 ICI部分废除了这种效果。 TNA处理下调M1巨噬细胞标记物和LPS刺激下BV-2细胞中的上调M2巨噬细胞标记物。通过TNA处理显着增加IL-10,而不显着变化IL-4和IL-13表达。 IL-10敲低完全废除了TNA对微胶囊M2极化的影响。结论:我们的数据展示了TNA在小鼠TBI模型中衰减神经元损失,并通过ERβ/ IL-10促进M2微胶质细胞。因此,TNA可以是用于TBI的潜在药物和/或由CNS中的小胶囊过度激活引起的疾病。 2020 Chen等人。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号